Trupanion (NASDAQ:TRUP) was downgraded by stock analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued on Tuesday.
A number of other research analysts have also commented on TRUP. ValuEngine lowered Trupanion from a “strong-buy” rating to a “buy” rating in a research report on Thursday, October 4th. Canaccord Genuity increased their price objective on Trupanion from $40.00 to $46.00 and gave the company a “buy” rating in a research report on Friday, August 3rd. Lake Street Capital reiterated a “buy” rating and issued a $46.00 price objective (up from $41.00) on shares of Trupanion in a research report on Friday, August 3rd. Stifel Nicolaus increased their price objective on Trupanion from $34.00 to $40.00 and gave the company a “buy” rating in a research report on Tuesday, July 10th. Finally, Craig Hallum began coverage on Trupanion in a research report on Thursday, July 19th. They issued a “buy” rating and a $55.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have given a buy rating to the stock. Trupanion presently has a consensus rating of “Buy” and a consensus price target of $45.22.
NASDAQ TRUP opened at $30.20 on Tuesday. The company has a market cap of $1.17 billion, a P/E ratio of -431.43 and a beta of 0.60. Trupanion has a one year low of $25.50 and a one year high of $46.70. The company has a debt-to-equity ratio of 0.16, a quick ratio of 3.04 and a current ratio of 3.04.
In other news, Director Murray B. Low sold 3,000 shares of the stock in a transaction on Friday, August 10th. The stock was sold at an average price of $38.12, for a total value of $114,360.00. Following the transaction, the director now owns 189,782 shares of the company’s stock, valued at approximately $7,234,489.84. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Darryl Rawlings sold 4,000 shares of the stock in a transaction on Wednesday, August 8th. The shares were sold at an average price of $38.18, for a total value of $152,720.00. Following the completion of the transaction, the chief executive officer now directly owns 1,293,989 shares in the company, valued at approximately $49,404,500.02. The disclosure for this sale can be found here. Insiders sold a total of 23,450 shares of company stock worth $901,839 over the last quarter. Corporate insiders own 20.70% of the company’s stock.
Hedge funds have recently bought and sold shares of the company. SG Americas Securities LLC acquired a new position in shares of Trupanion in the 2nd quarter valued at $100,000. Summit Trail Advisors LLC lifted its stake in shares of Trupanion by 2,638.0% in the 1st quarter. Summit Trail Advisors LLC now owns 109,876 shares of the financial services provider’s stock valued at $110,000 after purchasing an additional 105,863 shares during the period. First Mercantile Trust Co. acquired a new position in shares of Trupanion in the 2nd quarter valued at $142,000. US Bancorp DE lifted its stake in shares of Trupanion by 111.8% in the 2nd quarter. US Bancorp DE now owns 4,512 shares of the financial services provider’s stock valued at $175,000 after purchasing an additional 2,382 shares during the period. Finally, Xact Kapitalforvaltning AB acquired a new position in shares of Trupanion in the 2nd quarter valued at $224,000. 93.92% of the stock is currently owned by institutional investors.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Featured Story: Insider Trading
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.